Roth Capital initiated coverage on Better Choice Co with a new price target
$BTTR
Beverages (Production/Distribution)
Consumer Staples
Roth Capital initiated coverage of Better Choice Co with a rating of Buy and set a new price target of $7.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/26/2021 | $7.00 | Buy | Roth Capital |
| 7/15/2021 | $9.00 | Buy | DA Davidson |
SC 13G/A - Better Choice Co Inc. (0001471727) (Subject)
SC 13G - Better Choice Co Inc. (0001471727) (Subject)
SC 13G/A - Better Choice Co Inc. (0001471727) (Subject)
4 - Better Choice Co Inc. (0001471727) (Issuer)
4 - Better Choice Co Inc. (0001471727) (Issuer)
4 - Better Choice Co Inc. (0001471727) (Issuer)
TAMPA, Fla., March 11, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE:BTTR) ("Better Choice" or the "Company"), a pet health and wellness company, today announced that it has signed a binding Letter of Intent (LOI) to acquire 100% of Choice Specialty Pharmacy Group ("Seller"), a fully licensed and prominent provider of specialized pharmacy services in the U.S., through an option purchase agreement. This acquisition is expected to further strengthen Better Choice's specialty pharmacy presence in the U.S. and the purchase price is based on 6X of Seller's FY2024 Adjusted EBITDA1 of approximately USD $4.68 million1, and consideration will be comprised of stock and cash at closing.
TAMPA, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE:BTTR) ("Better Choice" or the "Company"), a pet health and wellness company, today announced it will host a conference call and webcast on Thursday, March 27, 2025, at 4:30 p.m. ET to discuss its financial results for the fourth quarter and full year 2024 and provide a business update. Additionally, we have filed a supplemental proxy statement. This filing is part of our ongoing commitment to transparency and shareholder engagement. The supplemental proxy statement can be accessed here. Conference Call and Webcast Information:Event: Fourth Quarter and Full Year 2024 Financial Results Conference CallDate:
TAMPA, Fla., March 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE:BTTR) ("Better Choice" or the "Company"), a pet health and wellness company, today announced the appointment of Dr. Paldeep S. Atwal as its United States Special Healthcare Advisor. Renowned for his expertise in rare and undiagnosed diseases, Dr. Atwal has dedicated his career to advancing the field of genomic medicine through cutting-edge diagnostics, research, and patient care. Dr. Atwal is a board-certified clinical and medical biochemical geneticist and the founder of Atwal Clinic for Genomic & Personalized Medicine, a premier private genetics clinic in Palm Beach, FL. Previously, he served as Medical Di
TAMPA, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE:BTTR) ("Better Choice" or the "Company"), a pet health and wellness company, today announced it will host a conference call and webcast on Thursday, March 27, 2025, at 4:30 p.m. ET to discuss its financial results for the fourth quarter and full year 2024 and provide a business update. Additionally, we have filed a supplemental proxy statement. This filing is part of our ongoing commitment to transparency and shareholder engagement. The supplemental proxy statement can be accessed here. Conference Call and Webcast Information:Event: Fourth Quarter and Full Year 2024 Financial Results Conference CallDate:
TAMPA, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE:BTTR) ("Better Choice" or "the Company"), a pet health and wellness company, today announced that as part of the acquisition of SRx Health Solutions Inc. (‘SRx Health'), a leading provider of innovative healthcare solutions, the capital stock distribution of Halo, Purely for Pets, Inc. has increased from an 8% to 17% dividend. The closing of the transaction is subject to customary closing conditions, including the receipt of required shareholder approvals from SRx Health and Better Choice. The transaction is expected to close during the first quarter of 2025. About Better Choice Company Inc. Better Choice Company
TAMPA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE:BTTR) ("Better Choice" or the "Company"), a pet health and wellness company, today announced it will host a conference call and webcast on Tuesday, November 12, 2024, at 4:30 p.m. ET to discuss its financial results for the third quarter 2024 and provide a business update. Conference Call and Webcast Information:Event: Third Quarter 2024 Financial Results Conference CallDate: Tuesday, November 12, 2024Time: 4:30 p.m. Eastern TimeLive Call: 1-888-348-8935 or 1-412-317-0454Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1695479&tp_key=5c885faf3c For interested individuals unable to join the conference cal
DEFA14A - Better Choice Co Inc. (0001471727) (Filer)
DEF 14A - Better Choice Co Inc. (0001471727) (Filer)
8-K - Better Choice Co Inc. (0001471727) (Filer)
4 - Better Choice Co Inc. (0001471727) (Issuer)
4 - Better Choice Co Inc. (0001471727) (Issuer)
Roth Capital initiated coverage of Better Choice Co with a rating of Buy and set a new price target of $7.00
DA Davidson initiated coverage of Better Choice Co with a rating of Buy and set a new price target of $9.00
TAMPA, Fla., March 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE:BTTR) ("Better Choice" or the "Company"), a pet health and wellness company, today announced the appointment of Dr. Paldeep S. Atwal as its United States Special Healthcare Advisor. Renowned for his expertise in rare and undiagnosed diseases, Dr. Atwal has dedicated his career to advancing the field of genomic medicine through cutting-edge diagnostics, research, and patient care. Dr. Atwal is a board-certified clinical and medical biochemical geneticist and the founder of Atwal Clinic for Genomic & Personalized Medicine, a premier private genetics clinic in Palm Beach, FL. Previously, he served as Medical Di
NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE:BTTR) ("Better Choice" or "the Company"), a pet health and wellness company, today announced it has appointed Kent Cunningham as Chief Executive Officer effective May 22, 2023. Mr. Cunningham is a passionate brand builder and business leader with over 25 years of CPG and Health & Wellness marketing and sales experience across a range of corporate environments and categories including accelerating growth within multinationals, brand turnarounds and high value exits in the private equity business for the likes of KKR & Co. Inc. Most recently, Mr. Cunningham was CEO of 1440 Foods, a sports and active nutrition company
NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE:BTTR) (the "Company" or "Better Choice"), a pet health and wellness company, today announced that it has appointed two new members to its Board of Directors, Lionel Conacher and Arlene Dickinson. They will replace current serving directors, Lori Taylor and Jeff Davis, effective September 28, 2021. Lionel Conacher joins Better Choice with over thirty years of financial experience, spanning senior positions in public companies in both Canada and the US, investment banking, private equity and venture capital. Mr. Conacher currently serves as Chairman of DXL Group (NASDAQ:DXLG), where he has successfully guided the re